Last reviewed · How we verify
NCT04656665
The Effectiveness of Aspirin on Preventing Pre-eclampsia
Phase 4 trial testing Aspirin in Pre-Eclampsia in 600 participants. Status unknown.
14 December 2022
Quick facts
| Lead sponsor | The Third Affiliated Hospital of Guangzhou Medical University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 600 |
| Start date | 15 March 2021 |
| Primary completion | 14 December 2022 |
| Estimated completion | 31 December 2022 |
Drugs / interventions tested
- Aspirin — full drug profile →
Conditions studied
- Pre-Eclampsia — all drugs for Pre-Eclampsia →
Sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Who can join
Adults 18 to 55, female only, with Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will explore the effectiveness of low-dose aspirin on preventing pre-eclampsia in high-risks pregnant women by comparing the incidence of pre-eclampsia and pregnancy outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04656665
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aspirin
Trials testing the same drug.
- NCT07525635 — Aspirin Dosing in Pregnancy · EARLY_PHASE1 · not yet recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
- NCT07373756 — Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk · Phase 4 · not yet recruiting
- NCT07180472 — Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol · Phase 4 · not yet recruiting
- NCT06638151 — Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) · Phase 2 · recruiting
Other recruiting trials for Pre-Eclampsia
Currently open trials in the same condition.
- NCT07245056 — Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia · NA · recruiting
- NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
- NCT06893510 — Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia · NA · recruiting
- NCT06122220 — Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia. · NA · recruiting
- NCT06779916 — Autophagy/Apoptosis Balance in Placental Vascular Pathologies · recruiting
Other The Third Affiliated Hospital of Guangzhou Medical University trials
Trials by the same sponsor.
- NCT07533929 — Incidence and Predictors of Elevated ALT in Postpartum CHB Mothers · not yet recruiting
- NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
- NCT06711601 — Ultrasound Evaluation of Two Anatomic Landmarks in Spinal Anesthesia for Cesarean Section: the Posterior Superior Iliac · recruiting
- NCT06420427 — Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery · recruiting
- NCT06383858 — The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04656665 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Affiliated Hospital of Guangzhou Medical University
- Last refreshed: 10 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04656665.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing